Volume 11, Number 6—June 2005
Perspective
Antimicrobial Resistance Determinants and Future Control
Table 3
Proportions of appropriate perioperative antimicrobial drug prophylaxis in Belgian hospitals after change in the reimbursement system*
1986 (%) | 1999 (%) | |
---|---|---|
Correct timing | 53 | 70 |
Correct indication | 92 | 97 |
Duration >48 h | 50 | 8 |
Choice of agent | ||
First-generation cephalosporin | 28 | 66 |
Second-generation cephalosporin | 17 | 29 |
*Source: Goossens et al (34).
References
- Livermore D. Can better prescribing turn the tide of resistance? Nat Rev Microbiol. 2004;2:73–8. DOIPubMedGoogle Scholar
- Weber JT, Courvalin P. An emptying quiver: antimicrobial drugs and resistance. Emerg Infect Dis. 2005;11:791–3. DOIPubMedGoogle Scholar
- Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr Opin Microbiol. 1999;2:489–93. DOIPubMedGoogle Scholar
- Harbarth S, Albrich W, Goldmann DA, Huebner J. Control of multiply resistant cocci: do international comparisons help? Lancet Infect Dis. 2001;1:251–61. DOIPubMedGoogle Scholar
- Nuermberger EL, Bishai WR. Antibiotic resistance in Streptococcus pneumoniae: what does the future hold? Clin Infect Dis. 2004;38(Suppl 4):S363–71. DOIPubMedGoogle Scholar
- Fischer JE, Harbarth S, Agthe AG, Benn A, Ringer SA, Goldmann DA, Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis. 2004;38:1383–90. DOIPubMedGoogle Scholar
- Christ-Crain M, Jaccard-Stolz D, Bingisser R, Gencay MM, Huber PR, Tamm M, Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet. 2004;363:600–7. DOIPubMedGoogle Scholar
- Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350:451–8. DOIPubMedGoogle Scholar
- Dunne WM Jr, Pinckard JK, Hooper LV. Clinical microbiology in the year 2025. J Clin Microbiol. 2002;40:3889–93. DOIPubMedGoogle Scholar
- Raoult D, Fournier PE, Drancourt M. What does the future hold for clinical microbiology? Nat Rev Microbiol. 2004;2:151–9. DOIPubMedGoogle Scholar
- Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588–98. DOIPubMedGoogle Scholar
- Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest. 2004;125:1791–9. DOIPubMedGoogle Scholar
- Molstad S, Lundborg CS, Karlsson AK, Cars O. Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis. 2002;34:366–71. DOIPubMedGoogle Scholar
- Patrick DM, Marra F, Hutchinson J, Monnet DL, Ng H, Bowie WR. Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? Clin Infect Dis. 2004;39:11–7. DOIPubMedGoogle Scholar
- Projan SJ, Shlaes DM. Antibacterial drug discovery: is it all downhill from here? Clin Microbiol Infect. 2004;10(Suppl 4):18–22. DOIPubMedGoogle Scholar
- Ganestam F, Lundborg CS, Grabowska K, Cars O, Linde A. Weekly antibiotic prescribing and influenza activity in Sweden: a study throughout 5 influenza seasons. Scand J Infect Dis. 2003;35:836–42. DOIPubMedGoogle Scholar
- Fleming DM, Ross AM, Cross KW, Kendall H. The reducing incidence of respiratory tract infection and its relation to antibiotic prescribing. Br J Gen Pract. 2003;53:778–83.PubMedGoogle Scholar
- Zanetti G, Blanc DS, Federli I, Berger MM, Chiolero R, Petignat C, Acinetobacter baumannii epidemic in a burn unit: usefulness of improved culture medium to assess environmental contamination. In: Infectious Diseases Society of America Annual Meeting; Boston, 2004; Abstract 219.
- Harbarth S, Albrich W, Brun-Buisson C. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis. 2002;8:1460–7.PubMedGoogle Scholar
- Bauraind I, Lopez-Lozano JM, Beyaert A, Marchal JL, Seys B, Yane F, Association between antibiotic sales and public campaigns for their appropriate use. JAMA. 2004;292:2468–70. DOIPubMedGoogle Scholar
- Finch RG, Metlay JP, Davey PG, Baker LJ. Educational interventions to improve antibiotic use in the community: report from the International Forum on Antibiotic Resistance (IFAR) colloquium, 2002. Lancet Infect Dis. 2004;4:44–53. DOIPubMedGoogle Scholar
- Oteo J, Lazaro E, de Abajo FJ, Baquero F, Campos J. Trends in antimicrobial resistance in 1,968 invasive Streptococcus pneumoniae strains isolated in Spanish hospitals (2001 to 2003): decreasing penicillin resistance in children's isolates. J Clin Microbiol. 2004;42:5571–7. DOIPubMedGoogle Scholar
- Waldvogel FA. Infectious diseases in the 21st century: old challenges and new opportunities. Int J Infect Dis. 2004;8:5–12. DOIPubMedGoogle Scholar
- Whitney CG, Klugman KP. Vaccines as tools against resistance: the example of pneumococcal conjugate vaccine. Semin Pediatr Infect Dis. 2004;15:86–93. DOIPubMedGoogle Scholar
- Reinert RR. Pneumococcal conjugate vaccines – a European perspective. Int J Med Microbiol. 2004;294:277–94. DOIPubMedGoogle Scholar
- Tiemersma EW, Bronzwaer SL, Lyytikainen O, Degener JE, Schrijnemakers P, Bruinsma N, Methicillin-resistant Staphylococcus aureus in Europe, 1999–2002. Emerg Infect Dis. 2004;10:1627–34.PubMedGoogle Scholar
- Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet. 2000;356:1307–12. DOIPubMedGoogle Scholar
- Tomic V, Svetina Sorli P, Trinkaus D, Sorli J, Widmer AF, Trampuz A. Comprehensive strategy to prevent nosocomial spread of methicillin-resistant Staphylococcus aureus in a highly endemic setting. Arch Intern Med. 2004;164:2038–43. DOIPubMedGoogle Scholar
- Cooper BS, Medley GF, Stone SP, Kibbler CC, Cookson BD, Roberts JA, Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes. Proc Natl Acad Sci U S A. 2004;101:10223–8. DOIPubMedGoogle Scholar
- Bell DM. Public health interventions and SARS spread, 2003. Emerg Infect Dis. 2004;10:1900–6.PubMedGoogle Scholar
- Carbon C, Bax RP. Regulating the use of antibiotics in the community. BMJ. 1998;317:663–5. DOIPubMedGoogle Scholar
- Bavestrello L, Cabello A, Casanova D. Impact of regulatory measures in the trends of community consumption of antibiotics in Chile. Rev Med Chil. 2002;130:1265–72. DOIPubMedGoogle Scholar
- Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation. 2000;101:2916–21.PubMedGoogle Scholar
- Goossens H, Peetermans W, Sion JP, Bossens M. Evidence-based perioperative antibiotic prophylaxis policy in Belgian hospitals after a change in the reimbursement system. Ned Tijdschr Geneeskd. 2001;145:1773–7.PubMedGoogle Scholar
- Harbarth S, Oberlander C. Do health care regulation and physician-industry interaction influence antibiotic resistance rates? The example of antimicrobial prescribing and dispensing in Japan. International Conference on Improving Use of Medicines. Chang Mai, Thailand: World Health Organization; 2004.
- Park S, Soumerai SB, Adams AS, Finkelstein JA, Jang S, Ross-Degnan D. Decreased inappropriate antibiotic use following a Korean national policy to prohibit medication dispensing by physicians. Health Policy Plan. 2005. In press. DOIPubMedGoogle Scholar
- Bruinsma N, Kristinsson KG, Bronzwaer S, Schrijnemakers P, Degener J, Tiemersma E, Trends of penicillin and erythromycin resistance among invasive Streptococcus pneumoniae in Europe. J Antimicrob Chemother. 2004;54:1045–50. DOIPubMedGoogle Scholar
- Reingold AL. Infectious disease epidemiology in the 21st century: will it be eradicated or will it reemerge? Epidemiol Rev. 2000;22:57–63.PubMedGoogle Scholar
- Chabbert YA. Aspects de la résistance des germes aux antibiotiques. Presse Med. 1952;79:1681–6.
- Cohen ML. Epidemiology of drug resistance: implications for a post-antimicrobial era. Science. 1992;257:1050–5. DOIPubMedGoogle Scholar
- Chambers HF. The changing epidemiology of Staphylococcus aureus. Emerg Infect Dis. 2001;7:178–82. DOIPubMedGoogle Scholar